KRAS and lung carcinoma: Previous studies showed that several tumor suppressor genes were inactivated in lung cancer patients, including TP53[8]RB1[9,10], and PTEN[11], while infrequent activating mutations or amplifications of PIK3CA, EGFR and KRAS, and MYC did occur in certain lung cancer patients [12].